ResMed (Germany) Top Insiders
RME Stock | EUR 230.00 3.20 1.41% |
ResMed employs about 8.2 K people. The company is managed by 10 executives with a total tenure of roughly 19040 years, averaging almost 1904.0 years of service per executive, having 816.0 employees per reported executive. Examination of ResMed's management performance can provide insight into the company performance.
Amy Wakeham Insider VP Communications |
Brett Sandercock Insider Chief Officer |
ResMed |
ResMed Management Team Effectiveness
The company has return on total asset (ROA) of 0.1155 % which means that it generated a profit of $0.1155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2352 %, meaning that it generated $0.2352 on every $100 dollars invested by stockholders. ResMed's management efficiency ratios could be used to measure how well ResMed manages its routine affairs as well as how well it operates its assets and liabilities.ResMed Workforce Comparison
ResMed Inc is currently regarded as top stock in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is at this time estimated at about 73,034. ResMed retains roughly 8,160 in number of employees claiming about 11% of all equities under Medical Instruments & Supplies industry.
The company has Profit Margin (PM) of 0.22 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28. ResMed Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. ResMed Inc Price Series Summation is a cross summation of ResMed price series and its benchmark/peer.
ResMed Notable Stakeholders
A ResMed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ResMed often face trade-offs trying to please all of them. ResMed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ResMed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Amy Wakeham | VP Communications | Profile | |
Brett Sandercock | Chief Officer | Profile | |
BE MBA | CEO Director | Profile | |
Robert Douglas | Pres COO | Profile | |
Vered Keisar | Chief Officer | Profile | |
AM AM | Founder Chairman | Profile | |
David Pendarvis | Global Officer | Profile | |
Kaushik Ghoshal | Pres Bus | Profile | |
Constance Bienfait | Director Relations | Profile | |
Urvashi Tyagi | Chief Officer | Profile |
About ResMed Management Performance
The success or failure of an entity such as ResMed Inc often depends on how effective the management is. ResMed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ResMed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ResMed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. RESMED INC is traded on Frankfurt Stock Exchange in Germany.
ResMed Workforce Analysis
Traditionally, organizations such as ResMed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ResMed within its industry.ResMed Manpower Efficiency
Return on ResMed Manpower
Revenue Per Employee | 438.5K | |
Revenue Per Executive | 357.8M | |
Net Income Per Employee | 95.5K | |
Net Income Per Executive | 77.9M |
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |